You can see my testimony at the PCAC if you watch the live stream or the pre-recorded version on youtube at: Also our 5 risks of peptides, like bpc-157, is a useful resource in this area: I really think the FDA will ultimately ignore the opinion of the largely financially conflicted PCAC
Right tool for right job based on mechanism-pathology matching
In the Dorr study, three healthy male subjects were subcutaneously administered 0.01 mg/kg of MT-II daily for two consecutive weeks, with one, two, or all three experiencing [5]: Somnolence Fatigue Nausea Stretching Yawning Spontaneous penile erections According to the Wessells et al
Its also added to various foods like fortified breakfast cereals
There are no hydroquinones in this formulation, so there is little chance of irritation in this sensitive area
You will in general be restricted in intake sources containing Vitamin B12